Dextromethorphan + Placebo
ApprovedTerminated 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Common Cold
Conditions
Common Cold, Infections, Upper Respiratory Tract
Trial Timeline
Dec 1, 2010 → Mar 1, 2011
NCT ID
NCT01257542About Dextromethorphan + Placebo
Dextromethorphan + Placebo is a approved stage product being developed by Novartis for Common Cold. The current trial status is terminated. This product is registered under clinical trial identifier NCT01257542. Target conditions include Common Cold, Infections, Upper Respiratory Tract.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01257542 | Approved | Terminated |
Competing Products
20 competing products in Common Cold